ALS Drug Radicava Now Available in U.S. - Muscular Dystrophy Association
List of drugs and compounds tested in human ALS clinical trials. | Download Table
FDA Approves Biogen's Qalsody for Treatment of SOD1-ALS - Quest | Muscular Dystrophy Association
List of drugs and compounds tested in ALS models and in ALS patients. | Download Table
Symptomatic medications for ALS. symptom Medication Dosage | Download Table
US Company Withdraws ALS Drug After It Fails In Trial | Barron's
What You Need to Know about Treatment Options For ALS - GoodRx
Amyotrophic Lateral Sclerosis (ALS) Treatment | ALS News Today
New ALS Medication Offers Infusion Of Hope | VA Houston Health Care | Veterans Affairs
New ALS treatment: Immunotherapy with T cells
Neuromuscular Notes: New and Emerging Therapies in ALS - Practical Neurology
FDA-Approved Drugs With Strong Preclinical Data, Failed in ALS Clinical... | Download Scientific Diagram
EU regulator declines to recommend Amylyx' ALS drug | Reuters
Oral pill slows rate of decline in ALS patients - UT Health San Antonio
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says - The New York Times
USF Health was among top U.S. medical centers to test new ALS treatment shown to significantly benefit patients - USF Health NewsUSF Health News
Amyotrophic Lateral Sclerosis - Practical Neurology
Emergency Medications - ALS
What Medications Are Used to Treat ALS? - Sharecare
Cancer, ALS Drugs That Don't Work Are Costing Americans Billions - Bloomberg
Amylyx ALS drug failure raises questions and concerns
ALS Emergency Medications
FDA Approves AMX0035 (Relyvrio) for ALS
Medication use and risk of amyotrophic lateral sclerosis—a systematic review | BMC Medicine | Full Text
Experimental ALS drug may be more effective than existing ones
